Intensive LDL Reduction Post Acute Coronary Syndromes: A Catalyst for Improved Outcomes

Heart Lung Circ. 2016 Nov;25(11):1051-1054. doi: 10.1016/j.hlc.2016.09.005.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Acute Coronary Syndrome / blood*
  • Acute Coronary Syndrome / drug therapy*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Lipoproteins, LDL / blood*
  • Randomized Controlled Trials as Topic

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipoproteins, LDL